Clinical Trial Update: Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated weight maintenance with sitagliptin added to metformin after liraglutide-induced weight loss in Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• Sitagliptin (sitagliptin)
• liraglutide (liraglutide)
• metformin (metformin)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Polycystic Ovary Syndrome, Body Weight | Phase 4 | Status: COMPLETED